Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Medicine and Health Sciences
Pulmonary Inflammation Is Regulated By The Levels Of The Vesicular Acetylcholine Transporter, Nathalia M. Pinheiro, Claudia J. C. P. Miranda, Adenir Perini, Niels O. S. Camara, Soraia K. P. Costa, Maria Isabel C. Alonso-Vale, Luciana C. Caperuto, Iolanda F. L. C. Tiberio, Marco A. M. Prado, Milton A. Martins, Vania F. Prado, Carla M. Prado
Pulmonary Inflammation Is Regulated By The Levels Of The Vesicular Acetylcholine Transporter, Nathalia M. Pinheiro, Claudia J. C. P. Miranda, Adenir Perini, Niels O. S. Camara, Soraia K. P. Costa, Maria Isabel C. Alonso-Vale, Luciana C. Caperuto, Iolanda F. L. C. Tiberio, Marco A. M. Prado, Milton A. Martins, Vania F. Prado, Carla M. Prado
Anatomy and Cell Biology Publications
Acetylcholine (ACh) plays a crucial role in physiological responses of both the central and the peripheral nervous system. Moreover, ACh was described as an anti-inflammatory mediator involved in the suppression of exacerbated innate response and cytokine release in various organs. However, the specific contributions of endogenous release ACh for inflammatory responses in the lung are not well understood. To address this question we have used mice with reduced levels of the vesicular acetylcholine transporter (VAChT), a protein required for ACh storage in secretory vesicles. VAChT deficiency induced airway inflammation with enhanced TNF-alpha and IL-4 content, but not IL-6, IL-13 and …
Skeletal Muscle Fibrosis In The Mdx/Utrn Plus /- Mouse Validates Its Suitability As A Murine Model Of Duchenne Muscular Dystrophy, Kelly M. Gutpell, William T. Hrinivich, Lisa M. Hoffman
Skeletal Muscle Fibrosis In The Mdx/Utrn Plus /- Mouse Validates Its Suitability As A Murine Model Of Duchenne Muscular Dystrophy, Kelly M. Gutpell, William T. Hrinivich, Lisa M. Hoffman
Anatomy and Cell Biology Publications
Various therapeutic approaches have been studied for the treatment of Duchenne muscular dystrophy (DMD), but none of these approaches have led to significant long-term effects in patients. One reason for this observed inefficacy may be the use of inappropriate animal models for the testing of therapeutic agents. The mdx mouse is the most widely used murine model of DMD, yet it does not model the fibrotic progression observed in patients. Other murine models of DMD are available that lack one or both alleles of utrophin, a functional analog of dystrophin. The aim of this study was to compare fibrosis and …